US 12174192
Methods for detecting and treating cancers having adenosine pathway activation
granted A61KA61K31/341A61K31/506
Quick answer
US patent 12174192 (Methods for detecting and treating cancers having adenosine pathway activation) held by Corvus Pharmaceuticals, Inc. expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corvus Pharmaceuticals, Inc.
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/341, A61K31/506, A61K31/517, A61P